Purdue University collaborates with Dr. Reddy's lab

Purdue University is working toward a strategic partnership with a pharmaceutical company in India. The school and Dr. Reddy's Laboratories Ltd. have signed a memorandum of understanding aimed at boosting research and development.

The collaboration will focus on pharmaceutical process and product development research in fields such as targeted drug delivery, manufacturing technology, scale-up of pharmaceutical operations, process engineering, as well as research and development methodologies and technology.

India has been a strategic focus for the university, which has nearly 1,500 students from the Asian nation. President Mitch Daniels is scheduled to visit India this fall. The agreement is also designed to push forward the Purdue Moves drug discovery initiative, which involves translating "basic research into life-changing treatments."

Purdue Executive Vice President for Research and Partnerships Suresh Garimella says "Dr. Reddy's Laboratories is a global pharmaceutical company that shares our mission to accelerate the rate at which new, advanced treatments make it to the millions of patients in need of relief. This partnership combines strengths that could lead to world-changing research."
DRL produces therapies in areas including gastrointestinal ailments, cardiovascular disease, pain management, oncology, anti-infectives, pediatrics and dermatology.

http://www.insideindianabusiness.com/newsitem.asp?ID=71794